1,650
Views
11
CrossRef citations to date
0
Altmetric
Introductory Article

The World Trade Center Health Program: an introduction to best practices

ORCID Icon, , , ORCID Icon, , , ORCID Icon, ORCID Icon, , , , , & show all

References

  • Murphy J, Brackbill RM, Thalji L, Dolan M, Pulliam P, Walker DJ. Measuring and maximizing coverage in the World Trade Center Health Registry. Stat Med. 2007;26(8):1688–1701. doi:10.1002/sim.2806.
  • Farfel M, DiGrande L, Brackbill R, et al. An overview of 9/11 experiences and respiratory and mental health conditions among World Trade Center Health Registry enrollees. J Urban Health. 2008;85(6):880–909. doi:10.1007/s11524-008-9317-4.
  • Wallingford KM, Snyder EM. Occupational exposures during the World Trade Center disaster response. Toxicol Ind Health. 2001;17(5-10):247–253. doi:10.1191/0748233701th112oa.
  • Lippmann M, Cohen MD, Chen LC. Health effects of World Trade Center (WTC) dust: an unprecedented disaster’s inadequate risk management. Crit Rev Toxicol. 2015;45(6):492–530. doi:10.3109/10408444.2015.1044601.
  • Santiago-Colón A, Daniels R, Reissman D, et al. World Trade Center Health Program: first decade of research. IJERPH. 2020;17(19):7290. doi:10.3390/ijerph17197290.
  • Daniels RD, Carreón T, Bilics JA, Reissman DB, Howard J. The World Trade Center Health Program: petitions for adding qualifying health conditions. Am J Ind Med. 2021;64(10):885–892. doi:10.1002/ajim.23267.
  • Friedman S, Cone J, Eros-Sarnyai M, et al. Clinical guidelines for adults exposed to the World Trade Center disaster. City Health Information. 2008;27(6):41–54.
  • NIOSH. 2018. Development of the inventory of 9/11 agents. Washington DC: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, https://wwwn.cdc.gov/ResearchGateway/Content/pdfs/Development_of_the_Inventory_of_9-11_Agents_20180717.pdf.
  • Clark R, Meeker G, Plumlee G, et al. 2002. USGS environmental studies of the World Trade Center area, New York City, after September 11, 2001 [US Geological Survey Web site]. http://pubs.usgs.gov/fs/fs-0050-02/fs-050-02_508.pdf.
  • Landrigan PJ, Lioy PJ, Thurston G, et al. Health and environmental consequences of the World Trade Center disaster. Environ Health Perspect. 2004;112(6):731–739. doi:10.1289/ehp.6702.
  • NIOSH. 2015. Policy and procedures for certification of physician determinations for aerodigestive and cancer health conditions. Washington DC: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, https://www.cdc.gov/wtc/pdfs/policies/WTCHPPPCertPhysDetFINAL20Feb2015-508.pdf.
  • Jordan HT, Osahan S, Li J, et al. Persistent mental and physical health impact of exposure to the September 11, 2001 World Trade Center terrorist attacks. Environ Health. 2019;18(1):12. doi:10.1186/s12940-019-0449-7.
  • Centers for Disease Control and Prevention (CDC). New York City Department of Health response to terrorist attack. MMWR Morb Mortal Wkly Rep. 2001;50(38):821–822.
  • Azofeifa A, Martin GR, Santiago-Colón A, Reissman DB, Howard J. World Trade Center Health Program - United States, 2012-2020. MMWR Surveill Summ. 2021;70(4):1–21. doi:10.15585/mmwr.ss7004a1.
  • Gerberich A, Spencer S, Ipema H. National guideline clearinghouse is no more: keep calm and search on. Ann Pharmacother. 2019;53(4):434–436. doi:10.1177/1060028018815852.
  • Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490. doi:10.1136/bmj.328.7454.1490.
  • Jue JJ, Cunningham S, Lohr K, et al. Developing and testing the agency for healthcare research and quality’s National Guideline Clearinghouse Extent of Adherence to Trustworthy Standards (NEATS) instrument. Ann Intern Med. 2019;170(7):480–487. doi:10.7326/M18-2950
  • Gupta S, Lieberman D, Anderson JC, et al. Recommendations for follow-up after colonoscopy and polypectomy: a consensus update by the US multi-society task force on colorectal cancer. Am J Gastroenterol. 2020;115(3):415–434. doi:10.14309/ajg.0000000000000544.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.